Interpolymer interactions between the countercharged polymers like Eudragit® EPO (polycation) and hypromellose acetate succinate. PDF | The objective of this investigation was to evaluate the potential of Eudragit EPO nanoparticles (EPO NP) in improving therapeutic efficacy. Download scientific diagram | Molecular structures of (a) MFA, (b) EUDRAGIT® EPO, and (c) EUDRAGIT® L from publication: Stabilization of a.

Author: Kekree Kikus
Country: Denmark
Language: English (Spanish)
Genre: Photos
Published (Last): 13 August 2018
Pages: 313
PDF File Size: 4.97 Mb
ePub File Size: 11.67 Mb
ISBN: 620-6-72301-242-4
Downloads: 59907
Price: Free* [*Free Regsitration Required]
Uploader: Gurr

It is a white powder with a characteristic amine-like odour. The prolonged drug release from the matrix system could be better explained by the in situ formation of PEC.

Evonik EUDRAGIT® E PO Copolymer

Effect of Dissolution Medium The effect of dissolution media pH 1. Ho C, Hwang GC. To study the release kinetics from the matrix tablets, the release data were fitted to the well-known exponential equation power law or Korsmeyer-Peppas equationwhich is often used to describe the drug release behavior from polymeric systems The objective of this study was to compare a novel controlled release tablet formulation based on interpolyelectrolyte complex PEC.

Poly butyl methacrylate-co- 2- demethylaminoeethyl methacrylate-co-methyl methacrylate 1: Acetaminophen was obtained from Eydragit laboratories limited Hyderabad, India as a gift sample.

Swelling Studies The swelling of the polymers upon hydration by the test medium was determined dpo a method similar to the equilibrium weight gain method as reported epk The data was analyzed by the regression coefficient method.

Please review our privacy policy. Users requiring more precise data for scientific or engineering calculations can click on the property value to see the original value as well as raw conversions to equivalent units.

The release profiles eudragiy also analyzed for the similarity factor f 2 values for the assessment of statistical difference or similarity between the release profiles. Influence of water soluble additives and HPMCP on drug release from Surelease-coated pellets containing tamsulosin hydrochloride.


The release rate was fastest for the lower polymer concentration formulation F10 with a K value of Novel hydrophilic chitosan—polyethylene oxide nanoparticles as protein carriers.

Case II transport or relaxation controlled delivery; the exponent n is 0. Where n is the number of pull points, R t is the reference profile at time point tand T t is the test profile at the same time point; the value of f 2 should be between 50 and To study the release kinetics, data obtained from in vitro drug release studies were plotted in various kinetic models: To prepare a novel controlled release tablet formulation using cationic EE and anionic enteric polymers and to evaluate their dissolution properties.

Drug and lactose monohydrate were passed through 30 sieve and mixed together for 10 min in a polybag.

There was a problem providing the content you requested

Use of hydroxypropyl methylcellulose acetate succinate in an enteric polymer matrix to design controlled-release tablets of amoxicillin trihydrate. Eudragit E, hypromellose acetate succinate, hypromellose phthalate polyelectrolyte complexation. Eur J Pharm Biopharm. The spectrum of EE Fig. Kinetic Analysis of Release Data To describe the kinetics of drug release from the selected matrix formulation F8release data was analyzed according to different kinetic equations.

An f 2 value of suggests that the test and reference profiles are identical and, as the value becomes smaller, the dissimilarity between release profiles increases.

They were then placed back in the dissolution vessel as quickly as possible. The carboxylic groups ionize in aqueous media at pH 5. Please read our License Agreement regarding materials data and our Privacy Policy.

The drug release from the matrix tablets containing a single polymer as matrix former in 0. Evonik Pharma polymers Release Profile Comparison The drug release profiles were compared using two model-independent methods, mean dissolution time MDTand similarity factor f 2 HPMCP is cellulose in which some of the hydroxyl groups are replaced with methyl ethers, 2-hydroxypropyl ethers, or phthalyl esters.


Drug Release Kinetics To study the release kinetics, data obtained from in vitro eudrafit release studies were plotted in various kinetic models: Handbook of pharmaceutical excipients. The manufactured tablets showed low weight variation indicating that the wet granulation method is an acceptable method for preparing good-quality matrix tablets.

Data sheets for overmetals, plastics, ceramics, and composites. The physical mixture of polymer mixtures showed the bands for the single components data not shown. The release rate was slowest for the higher polymer concentration formulation F8 with a K value of 7. Received Aug 4; Accepted Nov Abstract The objective of this study was to compare a novel controlled release tablet formulation based on interpolyelectrolyte complex PEC. This euragit polymer is soluble in aqueous media at a pH higher than 5.

Chemical structure of a EL and b EE polymer. On the other hand, sustained drug release was observed in pH 6. In vitro drug release testing from eudraglt was conducted according to the USP 27 apparatus 2 specifications using a dissolution tester Electrolab, India. The non-Fickian release or anomalous transport of drug occurred when the n values are between the limiting values of Fickian and case II transport.

Properties of melt extruded enteric matrix pellets. The matrix tablets of selected formulations were weighed and placed in tared metallic baskets.

It can be observed that the release rate did not vary much for tablets prepared with different polymer grades of HPMC AS. Various types of oppositely charged polyelectrolytes interact electrostatically in aqueous media to form an eudrqgit solid or PEC 2 — 5. Support Center Support Center.